NIH-funded research R01 grant

Magnetic nanoparticle stimulation to remove Alzheimer’s plaques

Official title: Magnetothermal brain stimulation towards the rescue of beta-amyloid pathology

Funded at Kent State University · NIH-11325425 · Data updated 2026-11-12

This work uses tiny magnetic particles and targeted magnetic fields to try to remove the amyloid plaques that build up in people with Alzheimer’s disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionKent State University
NIH-funded
Lab location1 site (Kent, United States)
Project startMay 15, 2022
Project endApril 30, 2027
Funding year2026
Award (this year)$379,697
NIH project number5R01AG076699-05
Project IDNIH-11325425 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be people with Alzheimer’s disease or mild cognitive impairment linked to amyloid pathology who meet safety and eligibility criteria for a magnetothermal intervention.

Less likely to help

People whose dementia is not driven by amyloid, those with very advanced Alzheimer’s, or individuals with medical conditions or implanted devices incompatible with magnetic fields may not receive benefit.

What this research studies

You would hear about a minimally invasive approach that uses superparamagnetic nanoparticles and a focused alternating magnetic field to create local heating and mechanical signals in the brain. The idea is to trigger biological processes that help clear toxic beta‑amyloid plaques and protect synapses. The research team will test this magnetothermal stimulation in lab models of Alzheimer’s disease and measure plaque clearance and effects on cognition. If preclinical results are promising, they plan steps toward translating the method for human testing.

Why it matters

Potential benefit: If successful, this approach could reduce amyloid plaques and potentially slow or improve memory loss in people with Alzheimer’s disease.

How similar studies have gone: Similar magnetothermal and nanoparticle approaches have shown promise in laboratory and animal studies but remain largely experimental with little evidence yet in humans.

Where this research is happening

  • Kent State University
    Kent, United States
    Active

Researchers

  • Principal investigator: Kim, Min Ho — Kent State University
  • Study coordinator: Kim, Min Ho

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.